Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) shares, rose in value, with the stock price up by 0.95% to the previous day’s close as strong demand from buyers drove the stock to $42.47.
Actively observing the price movement in the last trading, the stock closed the session at $42.07. Referring to stock’s 52-week performance, its high was $43.59, and the low was $19.59. On the whole, CERE has fluctuated by 0.21% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CERE’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CERE currently trading nearly 1.01% and 1.40% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 60.04, while the 7-day volatility ratio is showing 0.87% which for the 30-day chart, stands at 0.79%. Furthermore, Cerevel Therapeutics Holdings Inc (CERE)’s beta value is 1.48, and its average true range (ATR) is 0.36.
A comparison of Cerevel Therapeutics Holdings Inc (CERE) with its peers suggests the former has fared considerably weaker in the market. CERE showed an intraday change of 0.95% in last session, and over the past year, it grew by 51.30%%.
Data on historical trading for Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) indicates that the trading volumes over the past 3 months, they’ve averaged 1.40 million. According to company’s latest data on outstanding shares, there are 181.36 million shares outstanding.
Nearly 52.09% of Cerevel Therapeutics Holdings Inc’s shares belong to company insiders and institutional investors own 48.37% of the company’s shares. The stock has risen by 0.17% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CERE stock heading into the next quarter.
